Indrit Bègue

Dr. Indrit Bègue


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in NeuroImage: Clinical
Verified
Journal Article
Open access
DPDavid L. Perez
David L. Perez
TNTimothy R. Nicholson
Timothy R. Nicholson
AAAli A. Asadi-Pooya
Ali A. Asadi-Pooya
IBIndrit Bègue
Indrit Bègue
MBMatthew Butler
Matthew Butler
SASelma Aybek
Selma Aybek
• 1st Neuroimaging Workgroup Meeting in Functional Neurological Disorder (FND). • Underscores the importance of FND cohort characterization in brain imaging research. • Details methodological approaches taken in FND neuroimaging research to date. • Research agenda proposed to definitely elucidate the neural circuitry of FND. • Discussions underway regarding having FND researchers join the ENIGMA consortium.

3 February 2020 in Nature Human Behaviour
Verified
Journal Article
Closed access
PDF file
DRDobromir Rahnev
Dobromir Rahnev
KDKobe Desender
Kobe Desender
ALAlan L. F. Lee
Alan L. F. Lee
WAWilliam T. Adler
William T. Adler
DADavid Aguilar-Lleyda
David Aguilar-Lleyda
AZAriel Zylberberg
Ariel Zylberberg

1 January 2019 in NeuroImage: Clinical
Verified
Journal Article
Open access
IBIndrit Bègue
Indrit Bègue
CACaitlin Adams
Caitlin Adams
JSJ. R. Stone
J. R. Stone
DPDavid L. Perez
David L. Perez
Functional neurological (conversion) disorder (FND) is a condition at the interface of neurology and psychiatry. A "software" vs. "hardware" analogy describes abnormal neurobiological mechanisms occurring in the context of intact macroscopic brain structure. While useful for explanatory and treatment models, this framework may require more nuanced considerations in the context of quantitative structural neuroimaging findings in FND. Moreover, high co-occurrence of FND and somatic symptom disorders (SSD) as defined in DSM-IV (somatization disorder, somatoform pain disorder, and undifferentiated somatoform disorder; referred to as SSD for brevity in this article) raises the possibility of a partially overlapping pathophysiology. In this systematic review, we use a transdiagnostic approach to review and appraise the structural neuroimaging literature in FND and SSD. While larger sample size studies are needed for definitive characterization, this article highlights that individuals with FND and SSD may exhibit sensorimotor, prefrontal, striatal-thalamic, paralimbic, and limbic structural alterations. The structural neuroimaging literature is contextualized within the neurobiology of stress-related neuroplasticity, gender differences, psychiatric comorbidities, and the greater spectrum of functional somatic disorders. Future directions that could accelerate the characterization of the pathophysiology of FND and DSM-5 SSD are outlined, including "disease staging" discussions to contextualize subgroups with or without structural changes. Emerging neuroimaging evidence suggests that some individuals with FND and SSD may have a "software" and "hardware" problem, although if structural alterations are present the neural mechanisms of functional disorders remain distinct from lesional neurological conditions. Furthermore, it remains unclear whether structural alterations relate to predisposing vulnerabilities or consequences of the disorder.

1 December 2016 in Neuropsychologia
Verified
Journal Article
Closed access
RBRebekah L. Blakemore
Rebekah L. Blakemore
IBIndrit Bègue
Indrit Bègue
SGSilvio Galli
Silvio Galli
SASelma Aybek
Selma Aybek
PVPatrik Vuilleumier
Patrik Vuilleumier

1 November 2015 in Consciousness and Cognition
Verified
Journal Article
Closed access
IBIndrit Bègue
Indrit Bègue
YCYann Cojan
Yann Cojan
PVPatrik Vuilleumier
Patrik Vuilleumier

Verified
Journal Article
Open access
PDF file
Claudio L.A. BassettiClaudio L.A. Bassetti
Claudio L.A. Bassetti
Mirjam R HeldnerMirjam R Heldner
Mirjam R Heldner
KAKristina Adorjan
Kristina Adorjan
EAEmiliano Albanese
Emiliano Albanese
GAGilles Allali
Gilles Allali
LRLuca Remonda
Luca Remonda
The brain and its health are essential for our (physical mental, social, and spiritual) wellbeing, for being able to realize our potential as individuals, and also for a fair, well-functioning, and productive society. However, today the world is facing a healthcare crisis related to the very high (and increasing) burden of brain disorders. As a response to this crisis, the “Swiss Brain Health Plan” (SBHP) was conceptualized in the context of other initiatives launched to value, promote, and protect brain health over the entire life course. In the first section of this position paper, the following fundamental considerations of the SBHP are discussed: (1) the high (and increasing) burden of brain disorders in terms of prevalence (>50% of the population suffers from a brain disorder), disability, mortality, and costs; (2) the prevention of brain disorders; (3) the operational definition of brain health; (4) determinants of brain health; (5) international initiatives to promote brain (including mental) health including the World Health Organization (WHO) intersectorial global action plan on epilepsy and other neurological disorders (NDs) (IGAP) and the WHO comprehensive mental health action plan. In the second section of the paper, the five strategic objectives of the SBHP, which has the vision of promoting brain health for all across the entire life course, are presented: (1) to raise awareness; (2) strengthen cross-disciplinary and interprofessional training/educational programs for healthcare professionals; (3) foster research on brain health determinants and individualized prevention of brain disorders; (4) prioritize a holistic (non-disease-specific), integrated, person-centered public health approach to promote brain health and prevent brain disorders through collaborations across scientific, health care, commercial, societal and governmental stakeholders and insurance providers; (5) support, empower, and engage patients, caregivers, and patient organizations, and reduce the stigma and discrimination related to brain disorders. In the third section of the paper, the first (2024) steps in the implementation of the SHBP, which will be officially launched in Zurich on 22 November 2023, are presented: (1) a definition of the overall organization, governance, specific targets, and action areas of the SBHP; (2) the patronage and/or co-organization of events on such specific topics as brain research (Lausanne), dementia (Geneva), stroke (Basel), neurohumanities (Bellinzona), sleep (Lugano), and psychiatry (Zurich); (3) the conduction of a new study on the global burden of brain disorders in Switzerland; (4) the launching of an international Certificate of Advanced Studies (CAS) on Brain Health at the University of Bern. In the fourth section of the paper, there is a concise executive summary of the SBHP.